Learn about Cizzle Biotechnology Holdings plc and their innovative blood test for early lung cancer detection in their recently published Annual Report.
LONDON and MINNEAPOLIS, Sept. 19, 2023 /PRNewswire/ Bio-Techne Corporation and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress.